lcp
We have detected you are using Internet Explorer. To provide the best and most secure experience, please use a modern browser as we do not support Internet Explorer.

Eczema management strategies - clinical fact sheet & MCQ

18 March 2025 - Quality Use of Medicines Alliance

Fast_Track_CPD_Tag2.png

Eczema (atopic dermatitis) is a common, chronic, relapsing, inflammatory skin condition. It typically presents before 1 year of age and can be lifelong.

Allergy testing and elimination diets

  • People with eczema often have other allergic conditions, including food allergy, but food allergy does not cause eczema.

  • Results from skin or blood tests for food allergies do not predict foods that trigger eczema. Allergy testing should only be undertaken if recommended and interpreted by a clinical immunology/allergy specialist.

  • Common triggers for eczema flares include dry climate, overheating, irritants (fragranced products, chemicals, sand, grass or dirt), scratching, allergens (dust mites), stress, sweat and excessive saliva, hormones and infections.

  • Avoid elimination diets and changes to infant formulas in those without a confirmed food allergy as this may result in malnutrition, poor growth and the development of new food allergies.

Shared decision-making and care

Moisturisers

  • Improves skin hydration and maintains the skin barrier

  • Daily use reduces the number of flares and need for topical corticosteroids

  • Moisturisers with ceramides may repair the skin barrier more effectively than others, but patient needs and preferences should be considered

  • Avoid products containing:
    • animal or plant-derived proteins (e.g., nuts, coconut, milk) especially if a person has broken skin and does not readily eat the food or has an allergy to it

    • essential oils

    • aqueous cream containing sodium lauryl sulphate

    • benzalkonium chloride, methylchloroisothiazolinone (MCI) or methylisothiazolinone (MI)

Eczema_Care_Plan_moisturiser.png

Topical corticosteroids (TCS)

  • Beyond the use of daily moisturiser, topical corticosteroids are first-line for management of eczema, showing proven efficacy and safety

  • Treat until fully resolved: generously apply TCS before moisturiser, on all areas of inflammation (not just the worst areas) until the skin feels smooth and itch-free - without strict time limits

  • Treat early using appropriate potency to avoid a chronic cycle of inflammation

  • Prescribe appropriate quantities (consider PBS streamline authorities for higher quantities).

  • Ointments are more effective than creams. When choosing a formulation, consider site and patient preference, see algorithm for further details

clinical_essentials_blog_eczema_1.jpg

 clinical_essentials_eczema_2.jpg

Eczema beyond the physical symptoms

  • Eczema impacts the well-being and quality of life of both individuals and caregivers. 

  • Children with eczema are more likely to experience sleep deprivation, mood disturbances, inattention and learning difficulties at school.

  • Adults with eczema have an increased risk of mental health disorders, such as anxiety and depression, when compared to adults without the disease.

 

Claim your CPD

After reading the clinical summary above and reviewing the references, complete the quiz to gain 30 minutes of EA CPD and 30 minutes of RP CPD. 

You can either self-report CPD to your CPD home, or Medcast will track your learning via your personal CPD Tracker and you can download and report these points once a year. See our CPD Tracker FAQ.  

Quiz

Please log in or sign up for a free Medcast account to access the case study questions and achieve the CPD credits.

Registered users only

Log in or sign up for a free Medcast account to continue.

 

Quality Use of Medicines Alliance
Quality Use of Medicines Alliance

The Quality Use of Medicines Alliance a consortium of eight health and consumer organisations, will align their work across the two grants, awarded under the Australian Government’s Quality Use of Diagnostics, Therapeutics and Pathology (QUDTP) Program.  

FOLLOW QHUB

Receive QHUB updates to your inbox.

Or follow us on social media

Related Tags
Related Categories
Related News
Atrial fibrillation diagnosis and assessment - clinical fact sheet & MCQ

Medcast Medical Education Team

Brand icon

Atrial fibrillation (AF) is common and significantly impacts mortality, contributing to as many as 1 in 10 deaths in Australia. This FastTrack is the first of two, focusing on the diagnosis and management of AF, from the recommendations on opportunistic screening to identifying comorbidities and precipitating factors. Complete the quiz to earn 30mins EA and 30mins RP CPD.

15 mins READ
Government renews support for the QUM Alliance to tackle major health issues

Kate Clutton

Brand icon

The QUM Alliance welcomes new government grants to improve health literacy and medicine safety. Over three years, programs will tackle stroke prevention, osteoporosis, menopause, mental health and multimorbidity. Led by Medcast, the initiative supports health professionals and consumers, building on previous successes to reach priority populations.

Atrial fibrillation and stroke prevention: we can do better

Quality Use of Medicines Alliance

Brand icon

Too many patients with atrial fibrillation (AF) and an elevated risk of stroke are missing out on appropriate long-term anticoagulation, and this puts them at unacceptable risk of catastrophic stroke and death. This makes early detection, use of validated stroke and bleeding risk assessment tools, and prompt initiation of anticoagulation essential. 

5 mins READ